skip to primary navigation skip to content

Gabriel Recchia

Winton Centre for Risk and Evidence Communication

People

Dr Gabriel Recchia

Gabriel Recchia

Gabriel Recchia received his PhD in Cognitive Science from the University of Indiana in 2012. His current research concerns the communication of information about risks and benefits in ways that support comprehension and informed decision-making, and which take into account recipients' information needs and preferences. He also conducts research on distributional models and their applications in the cognitive and social sciences, and has studied at Stanford and the University of Memphis Institute for Intelligent Systems.

Gabriel leads on user interface design and evaluation of Predict: Breast and user-friendly genetic reports, including evaluations of the effect of design choices on trust and comprehension. He also contributes to the Centre's work on communicating information about societal risks, and to user interface design for other risk/benefit communication tools.

Can You Handle the Evidence?

Test your skill at navigating evidence-by-numbers with one of our quick quizzes.

Journalists & Press Officers
Do you know your absolute from your relative risks? Your ORs from your HRs? Test yourself here.
Medical Professionals
You know the difference between sensitivity and specificity, but what about lead-time and overdiagnosis bias? Examine yourself here.
Legal Professionals
Given a positive DNA match, what’s the likelihood of innocence? Check your grasp of forensic evidence & probability here.

Latest news

Latest data from the MHRA on blood clots associated with the Astra Zeneca COVID-19 vaccine

7 May 2021

We've produced some new graphics to illustrate the data released on 6th May 2021 on blood clots and the AstraZeneca vaccine from the MHRA

Risky Talk - Communicating Evidence to Policymakers

26 April 2021

Politicians and civil servants are hungry for data to help design effective policy. How do we best collect and communicate this evidence - to support good governance and public accountability? …

Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine

7 April 2021

Please note this article dates from 7th April 2021. New data from the MHRA and falling incidence of COVID-19 in the UK mean that these illustrations are no longer current. …

View all news